Biotech Investment Analyst – Drug Asset & Company Assessment

This is a fully remote position, open to applicants in United States.

📋 Description

• Develop and assess rubrics that evaluate commercial pharmaceuticals and drug development initiatives.

• Deliver comprehensive evaluations of the company and its assets, encompassing mechanisms, clinical data, competitive positioning, and value indicators.

• Evaluate the integrity of investment-style theses.

• Identify weak, overly optimistic, or absent assumptions.

• Conduct assessments for approximately 5–10 companies during the pilot phase.

• Complete roughly 10–20 hours of work over a 1–2 week pilot period.

• Operate as an independent contractor on projects aimed at training and improving AI systems.

⛳️ Requirements

• Biotech/healthcare investment analyst based in the US with a background in specialist funds.

• Knowledge of biotechnology/pharmaceutical development programs.

• Capability to evaluate a drug asset and the associated company comprehensively.

• Over 5 years of experience in assessing biotech/pharmaceutical companies or assets.

• Currently unable to support H1-B or STEM OPT candidates.

🏝️ Benefits

• Opportunity for ongoing engagement for high-performing contributors.

• Fully remote position that allows for flexible scheduling.

• Weekly payments through Stripe or Wise based on services provided.

• Competitive compensation.

• Collaboration with top-tier researchers.

• Chance to influence the development of the next generation of AI systems.

• Up to $800 for each successful referral, with no cap on the number of referrals.